A randomized double-blind placebo-controlled trial of thioctic acid in migraine prophylaxis.

Impaired mitochondrial phosphorylation potential may play a role in migraine pathogenesis. Metabolic enhancers, such as riboflavin or coenzyme Q, are effective in migraine prophylaxis and quasi-devoid of adverse effects. Thioctic acid (-lipoic acid) is another substance known to enhance energy metabolism in mitochondria and to be beneficial in diabetic neuropathy. After an open pilot study suggesting its therapeutic antimigraine potentials, we embarked therefore in a randomized controlled trial of thioctic acid (Thioctacid) in migraine prophylaxis steered by the Belgian Headache Society. Five... Mehr ...

Verfasser: Magis, Delphine
Ambrosini, Anna
Sándor, Peter
Jacquy, Jean
Laloux, Patrice
Schoenen, Jean
Dokumenttyp: Artikel
Erscheinungsdatum: 2007
Schlagwörter: Adult / Belgium / Double-Blind Method / Energy Metabolism / Female / Humans / Male / Middle Aged / Migraine Disorders / Mitochondria / Severity of Illness Index / Thioctic Acid / Treatment Outcome / Vitamin B Complex / Migraine prophylaxis
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-28928682
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://hdl.handle.net/2078.1/235444